Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy

A series of thirteen patients with acute myocardial infarction was studied. In the 12 patients heparinised on admission, there was a fall in serum hyaluronidase activity, free amino sugar and uronic acid levels. This contrasted with a rise in creatine kinase activity. In a single unheparinised patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical biochemistry 1980-04, Vol.13 (2), p.92-94
1. Verfasser: Salkie, M.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 94
container_issue 2
container_start_page 92
container_title Clinical biochemistry
container_volume 13
creator Salkie, M.L.
description A series of thirteen patients with acute myocardial infarction was studied. In the 12 patients heparinised on admission, there was a fall in serum hyaluronidase activity, free amino sugar and uronic acid levels. This contrasted with a rise in creatine kinase activity. In a single unheparinised patient, the hyaluronidase level rose. This suggests that necrotic cardiac tissue releases hyaluronidase. Any beneficial effects of the local release of hyaluronidase may be minimized by heparin therapy. Study of patients on a trial of intravenous bovine testicular hyaluronidase following acute myocardial infarction could detect no rise in hyaluronidase levels. This confirms previous reports that human serum inhibits bovine testicular hyaluronidase.
doi_str_mv 10.1016/S0009-9120(80)91263-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75165200</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009912080912631</els_id><sourcerecordid>75165200</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-4b9b1a0b9aa425d1664d5118e140daaac44e49bffd745baa6a04118c9c0611093</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0EKkvhJ1TyCcEhYCeOE58QqqCtVIkDcLYm9rg1cuzFTlrl3-PtrnrlNDN63_l6CLng7BNnXH7-yRhTjeIt-zCyjzXKruEvyI6PQ9e0qutekt2z5TV5U8qfWrZilGfkbOhGxQa5I49XYTOpwOxjuqspRDrjAlMKvszUpRDSo493FMy6IJ23ZCBbD4H66CCbxadIIVq63CNF59AshSZX1SXDA8a0Fnq_QVhzit5CwYMxw357S145CAXfneI5-f3926_L6-b2x9XN5dfbxnSSLY2Y1MSBTQpAtL3lUgrbcz4iF8wCgBEChZqcs4PoJwAJTFTZKMMk50x15-T9ce4-p78rlkXPvhgMASLW4_TQc9m3jFVjfzSanErJ6PQ--xnypjnTB-D6Cbg-0NQj00_ANa99F6cF6zSjfe46Ea76l6OO9csHj1kX4zEatD5XWtom_58N_wBEm5Na</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75165200</pqid></control><display><type>article</type><title>Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy</title><source>MEDLINE</source><source>ScienceDirect Pay Per View(PPV) Titles</source><creator>Salkie, M.L.</creator><creatorcontrib>Salkie, M.L.</creatorcontrib><description>A series of thirteen patients with acute myocardial infarction was studied. In the 12 patients heparinised on admission, there was a fall in serum hyaluronidase activity, free amino sugar and uronic acid levels. This contrasted with a rise in creatine kinase activity. In a single unheparinised patient, the hyaluronidase level rose. This suggests that necrotic cardiac tissue releases hyaluronidase. Any beneficial effects of the local release of hyaluronidase may be minimized by heparin therapy. Study of patients on a trial of intravenous bovine testicular hyaluronidase following acute myocardial infarction could detect no rise in hyaluronidase levels. This confirms previous reports that human serum inhibits bovine testicular hyaluronidase.</description><identifier>ISSN: 0009-9120</identifier><identifier>EISSN: 1873-2933</identifier><identifier>DOI: 10.1016/S0009-9120(80)91263-1</identifier><identifier>PMID: 7389076</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Glycosaminoglycans - metabolism ; Heparin - therapeutic use ; Humans ; Hyaluronoglucosaminidase - blood ; Hyaluronoglucosaminidase - therapeutic use ; Myocardial Infarction - drug therapy ; Myocardial Infarction - metabolism</subject><ispartof>Clinical biochemistry, 1980-04, Vol.13 (2), p.92-94</ispartof><rights>1980 Technicon Instruments Corporation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-4b9b1a0b9aa425d1664d5118e140daaac44e49bffd745baa6a04118c9c0611093</citedby><cites>FETCH-LOGICAL-c360t-4b9b1a0b9aa425d1664d5118e140daaac44e49bffd745baa6a04118c9c0611093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009912080912631$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7389076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salkie, M.L.</creatorcontrib><title>Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy</title><title>Clinical biochemistry</title><addtitle>Clin Biochem</addtitle><description>A series of thirteen patients with acute myocardial infarction was studied. In the 12 patients heparinised on admission, there was a fall in serum hyaluronidase activity, free amino sugar and uronic acid levels. This contrasted with a rise in creatine kinase activity. In a single unheparinised patient, the hyaluronidase level rose. This suggests that necrotic cardiac tissue releases hyaluronidase. Any beneficial effects of the local release of hyaluronidase may be minimized by heparin therapy. Study of patients on a trial of intravenous bovine testicular hyaluronidase following acute myocardial infarction could detect no rise in hyaluronidase levels. This confirms previous reports that human serum inhibits bovine testicular hyaluronidase.</description><subject>Glycosaminoglycans - metabolism</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Hyaluronoglucosaminidase - blood</subject><subject>Hyaluronoglucosaminidase - therapeutic use</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - metabolism</subject><issn>0009-9120</issn><issn>1873-2933</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi0EKkvhJ1TyCcEhYCeOE58QqqCtVIkDcLYm9rg1cuzFTlrl3-PtrnrlNDN63_l6CLng7BNnXH7-yRhTjeIt-zCyjzXKruEvyI6PQ9e0qutekt2z5TV5U8qfWrZilGfkbOhGxQa5I49XYTOpwOxjuqspRDrjAlMKvszUpRDSo493FMy6IJ23ZCBbD4H66CCbxadIIVq63CNF59AshSZX1SXDA8a0Fnq_QVhzit5CwYMxw357S145CAXfneI5-f3926_L6-b2x9XN5dfbxnSSLY2Y1MSBTQpAtL3lUgrbcz4iF8wCgBEChZqcs4PoJwAJTFTZKMMk50x15-T9ce4-p78rlkXPvhgMASLW4_TQc9m3jFVjfzSanErJ6PQ--xnypjnTB-D6Cbg-0NQj00_ANa99F6cF6zSjfe46Ea76l6OO9csHj1kX4zEatD5XWtom_58N_wBEm5Na</recordid><startdate>198004</startdate><enddate>198004</enddate><creator>Salkie, M.L.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198004</creationdate><title>Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy</title><author>Salkie, M.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-4b9b1a0b9aa425d1664d5118e140daaac44e49bffd745baa6a04118c9c0611093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Glycosaminoglycans - metabolism</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Hyaluronoglucosaminidase - blood</topic><topic>Hyaluronoglucosaminidase - therapeutic use</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salkie, M.L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salkie, M.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy</atitle><jtitle>Clinical biochemistry</jtitle><addtitle>Clin Biochem</addtitle><date>1980-04</date><risdate>1980</risdate><volume>13</volume><issue>2</issue><spage>92</spage><epage>94</epage><pages>92-94</pages><issn>0009-9120</issn><eissn>1873-2933</eissn><abstract>A series of thirteen patients with acute myocardial infarction was studied. In the 12 patients heparinised on admission, there was a fall in serum hyaluronidase activity, free amino sugar and uronic acid levels. This contrasted with a rise in creatine kinase activity. In a single unheparinised patient, the hyaluronidase level rose. This suggests that necrotic cardiac tissue releases hyaluronidase. Any beneficial effects of the local release of hyaluronidase may be minimized by heparin therapy. Study of patients on a trial of intravenous bovine testicular hyaluronidase following acute myocardial infarction could detect no rise in hyaluronidase levels. This confirms previous reports that human serum inhibits bovine testicular hyaluronidase.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7389076</pmid><doi>10.1016/S0009-9120(80)91263-1</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9120
ispartof Clinical biochemistry, 1980-04, Vol.13 (2), p.92-94
issn 0009-9120
1873-2933
language eng
recordid cdi_proquest_miscellaneous_75165200
source MEDLINE; ScienceDirect Pay Per View(PPV) Titles
subjects Glycosaminoglycans - metabolism
Heparin - therapeutic use
Humans
Hyaluronoglucosaminidase - blood
Hyaluronoglucosaminidase - therapeutic use
Myocardial Infarction - drug therapy
Myocardial Infarction - metabolism
title Glycosaminoglycan metabolism following acute myocardial infarction and the effects of intravenous hyaluronidase therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T13%3A49%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycosaminoglycan%20metabolism%20following%20acute%20myocardial%20infarction%20and%20the%20effects%20of%20intravenous%20hyaluronidase%20therapy&rft.jtitle=Clinical%20biochemistry&rft.au=Salkie,%20M.L.&rft.date=1980-04&rft.volume=13&rft.issue=2&rft.spage=92&rft.epage=94&rft.pages=92-94&rft.issn=0009-9120&rft.eissn=1873-2933&rft_id=info:doi/10.1016/S0009-9120(80)91263-1&rft_dat=%3Cproquest_cross%3E75165200%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75165200&rft_id=info:pmid/7389076&rft_els_id=S0009912080912631&rfr_iscdi=true